What is Puregraf 150 IU Injection?
Puregraf 150 IU Injection is a pharmaceutical preparation containing Menotrophin as its active ingredient. Manufactured by Gufic Biosciences Ltd, this injection is designed to aid women dealing with female infertility. It is widely used in Australia to stimulate ovarian follicular development and promote successful conception in women facing fertility challenges.
Uses
The primary use of Puregraf 150 IU Injection is to treat female infertility caused by ovulatory dysfunction. It assists women who have difficulty ovulating naturally to enhance their chances of pregnancy through controlled ovarian stimulation.
How it Works
Menotrophin in Puregraf combines hormones that mimic the body's natural follicle-stimulating hormone (FSH) and luteinizing hormone (LH). This combination promotes the development and maturation of ovarian follicles, leading to ovulation. Through this mechanism, the injection helps regulate and stimulate reproductive function necessary for conception.
Who Should Use It?
- Women diagnosed with anovulatory or oligo-ovulatory infertility.
- Those undergoing assisted reproductive techniques like in-vitro fertilization (IVF) or intrauterine insemination (IUI).
- Patients prescribed by a healthcare professional based on fertility evaluation.
Who Should Avoid It?
- Women with primary ovarian failure.
- Patients with uncontrolled thyroid or adrenal dysfunction.
- Individuals with known hypersensitivity to menotrophin or other ingredients.
- Women with abnormal uterine bleeding of unknown cause or ovarian cysts not related to polycystic ovary syndrome.
Benefits
- Effectively stimulates ovarian follicle growth to facilitate ovulation.
- Enhances natural fertility potential in women with ovulatory issues.
- Supports assisted reproductive technologies for improved outcomes.
- Produced by a reputable manufacturer, ensuring quality and consistency.
- Convenient sterile injectable form for accurate dosing.
Dosage
Dosage of Puregraf 150 IU Injection should be personalized based on individual response and medical guidance. Typically, treatment starts with a low dose which may be gradually increased. Injection is administered under medical supervision, commonly daily or on alternate days as prescribed. Close monitoring of ovarian response via ultrasound and hormone levels is essential to avoid complications.
Side Effects
Possible side effects may include:
- Ovarian hyperstimulation syndrome (OHSS) symptoms like abdominal pain and swelling.
- Headache or dizziness.
- Nausea and vomiting.
- Local injection site reactions such as redness or pain.
- Allergic reactions in rare cases.
Consult your doctor immediately if severe discomfort or unusual symptoms occur.
Safety Advice
- Only use under strict medical supervision.
- Inform your doctor of any allergies or existing medical conditions.
- Do not self-administer without proper training.
- Avoid use if pregnant or breastfeeding unless advised by a healthcare provider.
Drug Interactions
Puregraf 150 IU Injection may interact with other fertility treatments or hormone therapies. Always discuss your current medications with your doctor to prevent adverse interactions and to optimize treatment outcomes.
Storage Instructions
- Store the injection in a refrigerator at 2-8°C.
- Keep away from direct sunlight and moisture.
- Do not freeze the product.
- Keep out of reach of children.
FAQ
Q: How long does it take to see results after using Puregraf 150 IU Injection?
A: Results vary, but follicular development is typically monitored within 7 to 14 days of treatment initiation.
Q: Can this injection be used for all types of female infertility?
A: It is primarily intended for ovulatory dysfunction; your doctor will determine the suitability based on diagnosis.
Q: Is the injection painful?
A: Some discomfort at the injection site is common but usually mild and temporary.
Q: Do I need frequent monitoring while on this medication?
A: Yes, close medical supervision with ultrasound and hormone tests is essential.
Conclusion
Puregraf 150 IU Injection offers an effective and scientifically formulated option for Australian women facing challenges with infertility due to ovulatory disorders. Backed by the quality standards of Gufic Biosciences Ltd, this menotrophin-based injection assists in stimulating ovarian function safely when used as directed by healthcare professionals. With proper monitoring and adherence to medical advice, it can significantly enhance the chances of conception, empowering women on their journey to motherhood.
Leave A Review